Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.95 CHF | +4.04% | -9.62% | +40.40% |
Apr. 17 | Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member | CI |
Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 35.98M 38.32M 34.87M | Sales 2025 * | 25.95M 27.64M 25.16M | Capitalization | 134M 142M 129M |
---|---|---|---|---|---|
Net income 2024 * | 13M 13.85M 12.6M | Net income 2025 * | 4M 4.26M 3.88M | EV / Sales 2024 * | 4.52 x |
Net Debt 2024 * | 29.11M 31.01M 28.22M | Net Debt 2025 * | 2M 2.13M 1.94M | EV / Sales 2025 * | 5.22 x |
P/E ratio 2024 * |
9.19
x | P/E ratio 2025 * |
30.7
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.09% |
Latest transcript on Newron Pharmaceuticals S.p.A.
1 day | +4.04% | ||
1 week | -9.62% | ||
Current month | -10.44% | ||
1 month | -11.58% | ||
3 months | -5.05% | ||
6 months | +39.28% | ||
Current year | +40.40% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 60 | 12-05-14 |
Luca Benatti
FOU | Founder | 63 | 97-12-31 |
Roberto Galli
DFI | Director of Finance/CFO | - | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 07-12-31 | |
Luca Benatti
FOU | Founder | 63 | 97-12-31 |
Ulrich Köstlin
CHM | Chairman | 71 | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 6.95 | +4.04% | 209,830 |
24-04-18 | 6.68 | -7.86% | 162,247 |
24-04-17 | 7.25 | +0.42% | 39,646 |
24-04-16 | 7.22 | -2.70% | 57,608 |
24-04-15 | 7.42 | -3.51% | 56,712 |
Delayed Quote Swiss Exchange, April 19, 2024 at 11:30 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+40.40% | 142M | |
-5.99% | 83.66B | |
+2.76% | 40.41B | |
-24.88% | 28.26B | |
+53.61% | 24.53B | |
-8.08% | 16.82B | |
-33.74% | 13.39B | |
-16.63% | 11.75B | |
-11.19% | 11.69B | |
-2.25% | 8.13B |
- Stock Market
- Equities
- NWRN Stock